Crossmark

The efficacy and safety of immune combination therapy in patients with driver gene-negative non-small cell lung cancer with liver metastasis: a systematic review and network meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12885-025-14712-w

Published Online: 2025-08-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Weixing

Li, Bo

Gu, Yujia

Jin, Xiaoni

Li, Zirui

Guo, Wanjing

Lu, Xinxin

Jiang, Jun
Funding

Funding for this research was provided by:

The Science and Technology Agency of Qinghai Province (2022-ZJ-719)
License Information

Text and Data Mining valid from 2025-08-18

Version of Record valid from 2025-08-18
More Information

Article History

Received: 5 November 2024

Accepted: 18 July 2025

First Online: 18 August 2025

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below